Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Long-Term Debt Issuances (2016 - 2024)

Fortress Biotech (FBIO) has 10 years of Long-Term Debt Issuances data on record, last reported at -$33.7 million in Q4 2024.

  • For Q4 2024, Long-Term Debt Issuances fell 220.42% year-over-year to -$33.7 million; the TTM value through Sep 2024 reached $61.7 million, up 1134.36%, while the annual FY2023 figure was $28.0 million, 460.0% up from the prior year.
  • Long-Term Debt Issuances reached -$33.7 million in Q4 2024 per FBIO's latest filing, down from $33.7 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $33.7 million in Q3 2024 and bottomed at -$33.7 million in Q4 2024.
  • Average Long-Term Debt Issuances over 3 years is $5.5 million, with a median of $16.5 million recorded in 2022.
  • Peak YoY movement for Long-Term Debt Issuances: surged 460.0% in 2023, then tumbled 220.42% in 2024.
  • A 3-year view of Long-Term Debt Issuances shows it stood at $5.0 million in 2022, then soared by 460.0% to $28.0 million in 2023, then crashed by 220.42% to -$33.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were -$33.7 million in Q4 2024, $33.7 million in Q3 2024, and $28.0 million in Q4 2023.